Your browser doesn't support javascript.
loading
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer.
Hsieh, Rodney Cheng-En; Krishnan, Sunil; Wu, Ren-Chin; Boda, Akash R; Liu, Arthur; Winkler, Michelle; Hsu, Wen-Hao; Lin, Steven Hsesheng; Hung, Mien-Chie; Chan, Li-Chuan; Bhanu, Krithikaa Rajkumar; Srinivasamani, Anupallavi; De Azevedo, Ricardo Alexandre; Chou, Yung-Chih; DePinho, Ronald A; Gubin, Matthew; Vilar, Eduardo; Chen, Chao Hsien; Slay, Ravaen; Jayaprakash, Priyamvada; Hegde, Shweta Mahendra; Hartley, Genevieve; Lea, Spencer T; Prasad, Rishika; Morrow, Brittany; Couillault, Coline Agnes; Steiner, Madeline; Wang, Chun-Chieh; Venkatesulu, Bhanu Prasad; Taniguchi, Cullen; Kim, Yon Son Betty; Chen, Junjie; Rudqvist, Nils-Petter; Curran, Michael A.
Afiliación
  • Hsieh RC; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Krishnan S; University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Wu RC; Department of Radiation Oncology, Chang Gung Memorial Hospital at Linkou and Chang Gung University, Taoyuan, Taiwan.
  • Boda AR; Department of Radiation Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.
  • Liu A; Department of Pathology, Chang Gung Memorial Hospital at Linkou and Chang Gung University, Taoyuan, Taiwan.
  • Winkler M; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hsu WH; University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Lin SH; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hung MC; University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Chan LC; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bhanu KR; University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Srinivasamani A; University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • De Azevedo RA; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chou YC; University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • DePinho RA; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gubin M; Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Vilar E; Graduate Institute of Biomedical Sciences, Research Center for Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung, Taiwan.
  • Chen CH; Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Slay R; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jayaprakash P; University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Hegde SM; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hartley G; University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Lea ST; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Prasad R; Department of Radiation Oncology, Chang Gung Memorial Hospital at Linkou and Chang Gung University, Taoyuan, Taiwan.
  • Morrow B; University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Couillault CA; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Steiner M; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang CC; University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Venkatesulu BP; Parker Institute for Cancer Immunotherapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Taniguchi C; University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Kim YSB; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chen J; Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rudqvist NP; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Curran MA; University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
Sci Immunol ; 7(72): eabl9330, 2022 06 10.
Article en En | MEDLINE | ID: mdl-35687697
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Antígeno CD47 Límite: Animals / Humans Idioma: En Revista: Sci Immunol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Antígeno CD47 Límite: Animals / Humans Idioma: En Revista: Sci Immunol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos